<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral arterial vasospasm is a major complication of aneurysmal <z:hpo ids='HP_0002138'>subarachnoid haemorrhage</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The conventional treatment of this complication includes haemodilution, <z:e sem="disease" ids="C0546817" disease_type="Disease or Syndrome" abbrv="">hypervolaemia</z:e>, arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> and nimodipine </plain></SENT>
<SENT sid="2" pm="."><plain>Some patients do not respond to this therapy and require an intraarterial infusion of papaverine and/or a cerebral angioplasty </plain></SENT>
<SENT sid="3" pm="."><plain>Transcranial Doppler detects <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>However it does not provide an accurate metabolic information on the ischaemic status of the cerebral tissue </plain></SENT>
<SENT sid="5" pm="."><plain>This article describes the monitoring of jugular venous bulb oxygen saturation to obtain a real time information on the metabolic effect of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> and its variations after intra-arterial infusion of papaverine </plain></SENT>
</text></document>